UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

 

 

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934 (Amendment No.     )

 

 

Filed by the Registrant  ☒                             Filed by a Party other than the Registrant  ☐

Check the appropriate box:

 

  Preliminary Proxy Statement
  Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
  Definitive Proxy Statement
  Definitive Additional Materials
  Soliciting Material under Rule 14a-12

MEDNAX, INC.

(Name of Registrant as Specified In Its Charter)

 

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

Payment of Filing Fee (Check the appropriate box):

  No Fee Required.
  Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
  (1)  

Title of each class of securities to which transaction applies:

 

     

  (2)  

Aggregate number of securities to which transaction applies:

 

     

  (3)  

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

 

     

  (4)  

Proposed maximum aggregate value of transaction:

 

     

  (5)  

Total fee paid:

 

     

  Fee paid previously with preliminary materials:
  Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
  (1)  

Amount Previously Paid:

 

     

  (2)  

Form, Schedule or Registration Statement No.:

 

     

  (3)  

Filing Party:

 

     

  (4)  

Date Filed:

 

     

 

 

 


*** Exercise Your Right to Vote ***

Important Notice Regarding the Availability of Proxy Materials for the

Shareholder Meeting to Be Held on September 9, 2020.

 

    

LOGO

 

 

MEDNAX, INC.

 

LOGO

 

MEDNAX, INC.

1301 CONCORD TERRACE

SUNRISE, FL 33323-2825

  

 

Meeting Information

  

 

Meeting Type:         Annual

  

For holders as of:         July 2, 2020

  

Date: September 9, 2020 Time: 10:30 AM ET

  

Location: Meeting live via the Internet-please visit

  

                 www.virtualshareholdermeeting.com/MD2020

  

 

The company will be hosting the meeting live via the Internet this year. To attend the meeting via the Internet please visit www.virtualshareholdermeeting.com/MD2020 and be sure to have the information that is printed in the box marked by the arrow LOGO (located on the following page).

  

 

You are receiving this communication because you hold shares in the company named above.

  

 

This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet.

  

You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side).

  

 

We encourage you to access and review all of the important information contained in the proxy materials before voting.

 

  

See the reverse side of this notice to obtain proxy materials and voting instructions.


    

   — Before You Vote—
  

How to Access the Proxy Materials

 

  

 

Proxy Materials Available to VIEW or RECEIVE:

  

NOTICE AND PROXY STATEMENT         ANNUAL REPORT

  

How to View Online:

  

Have the information that is printed in the box marked by the arrow LOGO (located on the following page) and visit: www.proxyvote.com.

  

 

How to Request and Receive a PAPER or E-MAIL Copy:

  

If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:

  

1) BY INTERNET:         www.proxyvote.com

  

2) BY TELEPHONE:     1-800-579-1639

  

3) BY E-MAIL*:               sendmaterial@proxyvote.com

  

* If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the arrow LOGO (located on the following page) in the subject line.

  

Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before August 26, 2020 to facilitate timely delivery.

   —How To Vote —
  

Please Choose One of the Following Voting Methods

 

LOGO     

  

 

Vote By Internet:

  

      Before The Meeting:

  

Go to www.proxyvote.com. Have the information that is printed in the box marked by the arrow LOGO (located on the following page) available and follow the instructions.

  

      During The Meeting:

  

Go to www.virtualshareholdermeeting.com/MD2020. Have the information that is printed in the box marked by the arrow LOGO (located on the following page) available and follow the instructions.

  

Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.


      

 

            Voting Items            

     

    

 

The Board of Directors recommends you vote FOR the following:

  
 

 

1.

  

 

Election of Directors

     
    

Nominees:

     
    

01)

  

Karey D. Barker

  

07)

  

Mark S. Ordan

    

02)

  

Waldemar A. Carlo, M.D.                

  

08)

  

Michael A. Rucker

    

03)

  

Paul G. Gabos

  

09)

  

Guy P. Sansone

    

04)

  

Manuel Kadre

  

10)

  

John M. Starcher, Jr.

    

05)

  

Thomas A. McEachin

  

11)

  

Shirley A. Weis

    

06)

  

Roger J. Medel, M.D.

     
 

The Board of Directors recommends you vote FOR proposals 2, 3, 4 and 5.

 

2.

  

Proposal to approve the Articles of Amendment to the Amended and Restated Articles of Incorporation, as amended, of MEDNAX, Inc. to change the Company’s name to “Pediatrix Medical Group, Inc.”

 

3.

  

Proposal to approve the Articles of Amendment to the Amended and Restated Articles of Incorporation, as amended, of MEDNAX Services, Inc., a subsidiary of the Company, to change its name to “PMG Services, Inc.”

 

4.

  

Proposal to ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2020 fiscal year.

 

5.

  

Proposal to approve, by non-binding advisory vote, the compensation of our named executive officers for the 2019 fiscal year.

 

NOTE: At the Shareholder Meeting, shareholders will be asked to consider and act upon such other business as may properly come before the meeting, or any adjournment or postponement thereof.

LOGO

 


 

 

    

 

 

LOGO

Pediatrix Medical (NYSE:MD)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Pediatrix Medical Charts.
Pediatrix Medical (NYSE:MD)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Pediatrix Medical Charts.